The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $67.34

Today's change+0.97 +1.46%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $67.34

Today's change+0.97 +1.46%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Express Scripts Holding Co up (U.S.)$0.97

Express Scripts Holding Co closed up Friday by (U.S.)$0.97 or 1.46% to (U.S.)$67.34. Over the last five days, shares have lost 0.74% and sit 2.73% above their 52-week low. This security has underperformed the S&P 500 by 9.60% during the last year.

Key company metrics

  • Open(U.S.) $67.36
  • Previous close(U.S.) $66.37
  • High(U.S.) $67.62
  • Low(U.S.) $66.70
  • Bid / Ask-- / --
  • YTD % change-22.96%
  • Volume3,073,404
  • Average volume (10-day)5,165,919
  • Average volume (1-month)6,387,895
  • Average volume (3-month)4,860,209
  • 52-week range(U.S.) $65.55 to (U.S.) $94.61
  • Beta1.44
  • Trailing P/E20.79×
  • P/E 1 year forward12.17×
  • Forward PEG0.99×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.24
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.27%

Based on its net profit margin of 2.27%, Express Scripts Holding Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue25,22325,45424,90026,313
Total other revenue--------
Total revenue25,22325,45424,90026,313
Gross profit2,2192,1721,8892,275
Total cost of revenue23,00423,28223,01124,038
Total operating expense24,05624,32224,07325,370
Selling / general / administrative939910953950
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)113129109383
Other operating expenses, total--------
Operating income1,1661,133827943
Interest income (expense), net non-operating-128-132-116-122
Gain (loss) on sale of assets--------
Other--------
Income before tax1,0461,006716831
Income after tax667606447589
Income tax, total378400268242
Net income662600441582
Total adjustments to net income--------
Net income before extra. items662600441582
Minority interest-6-6-6-7
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items662600441582
Inc. avail. to common incl. extra. items662600441582
Diluted net income662600441582
Dilution adjustment--------
Diluted weighted average shares682681735738
Diluted EPS excluding extraordinary itemsvalue per share0.970.880.600.79
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.080.990.691.16